The Price of Binge Watching: Subclinical Atherosclerosis and Sleep Quality

Fragmented sleep and lower sleeping time have a higher risk of subclinical atherosclerosis in multiple territories. These results highlight the importance of good sleeping habits for good health and against cardiovascular disease. This comes out when binge watching online series on TV or any mobile device has become the norm. Online “streaming” is silently stressing our arteries out.

The aim of this study was to assess the relation between sleep parameters and subclinical atherosclerosis in an asymptomatic middle age population. In addition, researchers looked at conventional risk factors, eating habits, etc.

 

Sleep patterns were assessed (actigraphic measure) during 7 days in 3974 participants (45.8 ± 4.3 years; 62.6% men) and four groups were defined: very short (< 6 hours), short (6 a 7 horas), reference duration (7 to 8 hours) and prolonged sleep (>8 hours).



Read also: Anticoagulation Plays a Controversial Role in TAVR.


Carotid and femoral 3D vascular ultrasound was performed to assess Noncoronary atherosclerosis and coronary calcification.

 

After adjusting for conventional risk factors, very short sleep duration was associated with much higher atherosclerosis than reference duration sleep (OR: 1.27; CI 95%: 1.06 to 1.52; p=0.008). Participants with fragmented sleep also presented higher atherosclerosis burden in noncoronary territories.


Read also: The “Ten Commandments” of Myocardial Revascularization According to Europe.


Coronary calcification was similar across all groups.

 

Conclusion

Short sleep and fragmented sleep are independently associated with subclinical atherosclerosis in multiple territories. Sleeping well should be included in the advice “pack” we give our patients.

Original title: Association of Sleep Duration and Quality with Subclinical Atherosclerosis.

Reference: Fernando Domínguez et al. J Am Coll Cardiol 2019;73:134–44.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Transcatheter Pulmonary Valve Implantation with a Self-Expanding Valve: Outcomes at 3 Years

Pulmonary regurgitation (PR) is a common condition in patients who have undergone surgical repair of Tetralogy of Fallot or other pathologies involving the right...

RACE Trial: Effect of Balloon Pulmonary Angioplasty and Riociguat on Right Ventricular Afterload and Function in Chronic Thromboembolic Pulmonary Hypertension

Even though pulmonary endarterectomy is the treatment of choice for chronic thromboembolic pulmonary hypertension (CTEPH), up to 40% of patients are not candidates because...

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...

Measuring Post-TAVI Gradients and Their Implications: Are Invasive and Echocardiographic Assessments Comparable?

Transcatheter aortic valve implantation (TAVI) is considered the treatment of choice for a significant proportion of patients with symptomatic aortic stenosis. Outcomes have improved...

Another Blow for Intra-Aortic Balloon Pumo Counterpulsation? Randomized Study on Its Use in Chronic Heart Failure Progressing to Cardiogenic Shock

Cardiogenic shock (CS) remains a condition with extremely high mortality (around 50%). While most therapies for this pathology have been studied in CS secondary...